Organization type
- Foundation
Early phases
- Biomarker identification
- Target validation – Hypothesis verification
Screening
-
Assay development
- In vitro screening models
- In vivo screening models
Optimization phases
- In vitro cellular and organotypic 3D models (including assay/model development and testing)
- In vivo animal models (including assay/model development and testing)
-
Preclinical phase (including assay/model development and testing)(non-regulatory and regulatory)
- ADME / DMPK
- Safety
- Toxicology
Functional areas
- Artificial intelligence
-
Molecular and cellular biology
- Cell line generation
- Flow cytometry
- qPCR
Terapeutic areas
- Autoimmunity / Inflammation
- Blood and lymphatic system
- Cardiovascular
Additional activities
- Government initiatives supporting drug and research collaborations